Friedrich Overkamp

Prevalence of cancer survivors in the United States

Latest advances in hepatocellular carcinoma management and prevention through advanced technologies

Gemcitabine combined with the monoclonal antibody nimotuzumab is an active first-line regimen inKRAS wildtype patients with locally advanced or metastatic pancreatic cancer: a multicenter, randomized phase IIb study

Breast cancer patients' expectations in respect of the physician–patient relationship and treatment management results of a survey of 617 patients